Muscelli, E
I am very happy with your product so far
PMID: 2 AbererFHochfellnerDASourijHMaderJK
Based on the strength of the clinical data, we expect Wegovy to be added to formularies with utilization management restrictions for prior authorization to prevent off-label use, shorter initial approval periods (e.g., six months approved initially) to ensure efficacy, and quantity limits to reduce stockpiling and waste
200,201 Additionally, preventive vaccines against influenza viruses, 202,203 respiratory syncytial virus, 204 rabies virus, 205 and other viruses, as well as cancer-targeted therapeutic vaccines, 206,207,208 are being continuously researched and developed, which further reflect the application prospects of mRNA vaccines